Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities
Title:
Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities
Author:
McGoon, Michael D. Frost, Adaani E. Oudiz, Ronald J. Badesch, David B. Galie, Nazzareno Olschewski, Horst McLaughlin, Vallerie V. Gerber, Michael J. Dufton, Chris Despain, Darrin J. Rubin, Lewis J.